Effect of rifampicin & isoniazid on the steady state pharmacokinetics of moxifloxacin

BACKGROUND & OBJECTIVES: Moxifloxacin (MFX) is reported to have promising antimycobacterial activity, and has a potential to shorten tuberculosis (TB) treatment. We undertook this study to examine the influence of rifampicin (RMP) and isoniazid (INH) on the steady state pharmacokinetics of MFX i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramachandran, Geetha, Kumar, A.K. Hemanth, Srinivasan, R., Geetharani, A., Sugirda, P., Nandhakumar, B., Nandini, R., Tharani, C. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612327/
https://www.ncbi.nlm.nih.gov/pubmed/23391793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612327/
https://www.ncbi.nlm.nih.gov/pubmed/23391793

Ejemplares similares